Identifying Kinase Inhibitors as Potential Adjuvant Chemotherapeutics in Treatment for Ovarian Cancer

被引：0
|
作者：
Anliker, Clair [1 ]
Corradi, Anna [1 ]
Wallert, Mark [1 ]
机构：
[1] Bemidji State Univ, Bemidji, MN USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.06095
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line
    Pengetnze, Y
    Steed, M
    Roby, KF
    Terranova, PF
    Taylor, CC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (02) : 377 - 383
  • [32] Therapeutic potential of Aurora kinase inhibitors in cancer
    Naruganahalli, Krishna S.
    Lakshmanan, Manikandan
    Dastidar, Sunanda G.
    Ray, Abhijit
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (12) : 1044 - 1051
  • [33] The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer
    Djedovic, Vladimir
    Lee, Yoo-Young
    Kollara, Alexandra
    May, Taymaa
    Brown, Theodore J.
    HORMONES & CANCER, 2018, 9 (02): : 95 - 107
  • [34] The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer
    Vladimir Djedovic
    Yoo-Young Lee
    Alexandra Kollara
    Taymaa May
    Theodore J. Brown
    Hormones and Cancer, 2018, 9 : 95 - 107
  • [35] Farnesyltransferase inhibitors: A new class of cancer chemotherapeutics
    Koblan, KS
    Kohl, NE
    Omer, CA
    Anthony, NJ
    Conner, MW
    deSolms, SJ
    Williams, TM
    Graham, SL
    Hartman, GD
    Oliff, A
    Gibbs, JB
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (03) : 688 - 692
  • [36] Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment
    Zeng, Xiangyang
    Yi, Shuijing
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (06) : 1085 - 1089
  • [37] Angiogenesis Inhibitors in the Treatment of Epithelial Ovarian Cancer
    Han, Ernest S.
    Wakabayashi, Mark
    Leong, Lucille
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (01) : 22 - 33
  • [38] Angiogenesis inhibitors for the treatment of epithelial ovarian cancer
    Gaitskell, Kezia
    Rogozinska, Ewelina
    Platt, Sarah
    Chen, Yifan
    Abd El Aziz, Mohamed
    Tattersall, Abigail
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (04):
  • [39] Update on PARP Inhibitors for the Treatment of Ovarian Cancer
    Liu, Joyce
    Matulonis, Ursula A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (02) : 100 - 110
  • [40] PARP inhibitors in the treatment of ovarian cancer: a review
    Washington, Christina R.
    Moore, Kathleen N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 1 - 6
12345